System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Cédric Lenormand is an expert in Dermatology at Hôpitaux Universitaires de Strasbourg (France). Cédric Lenormand has authored 121 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 470 (community average: 125). How the SLR is computed.

LeadR Profile

Cédric Lenormand Hôpitaux Universitaires de Strasbourg France
470 ScienceLeadR Reputation 470

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Infectiology - Cardiology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2012 - 2026
Source: PubMed

Hôpitaux Universitaires de Strasbourg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 121

Citations

Citations: 729 1st author: 27 Last author: 21 Unique author: 5

Main journals

Ann Dermatol Venereol 34
Annales de dermatologie et de vénéréologie, FMC 14
J Am Acad Dermatol 5
Annales de Dermatologie et de Vénéréologie - FMC 4
Infect Dis Now 4

Best Journals

N Engl J Med 2
Ann Oncol 1
J Clin Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Author's reply to Letter to the Editor: When lightning strikes? An interdisciplinary educational opportunity between cardiology and forensic pathology.
PMID 42486423 — arrhythmias, cardiac, pathology, forensic pathology, cardiology, strikes, employee, lightning		Heart Rhythm20260
Reticular telangiectatic erythema: an underrecognized complication of cardiovascular implantable electronic devices.
PMID 42276268 — arrhythmias, cardiac, telangiectasis, erythema		Heart Rhythm20262
Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.
PMID 42090793 — skin, ivermectin, absenteeism, permethrin, scabies, therapeutics		N Engl J Med Top journal20260
Unusual Location of a Cutaneous Granular Cell Tumor: A Case Report and Review of the Literature.
PMID 42077696 — cells, immunohistochemistry, neoplasms, sarcoma, granular cell tumor, dermatofibrosarcoma		Cureus20260
Association between palisaded and interstitial granulomatous dermatoses and haematological neoplasms: evidence beyond coincidence?
PMID 41967120 — cells, granuloma, dermatitis, neoplasms, skin diseases, dermatology		Clin Exp Dermatol20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Director: 1

By phase:

N/A 5
Phase 3 3
Phase 4 1

By status:

Unknown 4
Completed 3
Not yet recruiting 1
Recruiting 1

By type:

Interventional 6
Observational 3

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 1
multicentricup10 3

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Prophylaxis of Recurrent Erysipelas in Lower Limbs compreSsion thErapy vs aNTibiotics and Compression Therapy
NCT07549594 — nurses, research design, cellulitis, telemedicine, emollients, erysipelas, penicillin v, therapeutics, random allocation, infections, stockings, compression, male		Phase 4Not yet recruiting2026
Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma a Single center Retrospective Study Between 2013 and 2021
NCT07302607 — melanoma, retrospective studies, immunotherapy, therapeutics		N/ARecruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS